PPT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.631560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.207600E-02
Normal-vs-Stage2
2.024100E-02
Normal-vs-Stage3
2.500400E-02
Normal-vs-Stage4
1.425030E-01
Stage1-vs-Stage2
7.594400E-01
Stage1-vs-Stage3
2.788600E-01
Stage1-vs-Stage4
2.293800E-01
Stage2-vs-Stage3
2.027000E-01
Stage2-vs-Stage4
4.364800E-01
Stage3-vs-Stage4
7.853800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.255510E-02
Normal-vs-AfricanAmerican
2.135000E-01
Normal-vs-Asian
3.514400E-02
Caucasian-vs-AfricanAmerican
5.246400E-01
Caucasian-vs-Asian
2.134200E-01
AfricanAmerican-vs-Asian
3.225400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.395700E-03
Normal-vs-Female
3.950000E-02
Male-vs-Female
1.431390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.473980E-01
Normal-vs-Age(41-60Yrs)
6.165500E-02
Normal-vs-Age(61-80Yrs)
6.781400E-03
Normal-vs-Age(81-100Yrs)
7.199600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.234800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.071400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.009400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.204700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.605200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.059600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.597700E-03
Normal-vs-Daily Drinker
2.552000E-02
Normal-vs-Weekly Drinker
4.697800E-02
Normal-vs-Occasional Drinker
8.300000E-02
Normal-vs-Social Drinker
6.826100E-02
Non Drinker-vs-Daily Drinker
2.889400E-01
Non Drinker-vs-Weekly Drinker
4.072600E-01
Non Drinker-vs-Occasional Drinker
5.236000E-02
Non Drinker-vs-Social Drinker
1.547440E-01
Daily Drinker-vs-Weekly Drinker
9.510800E-01
Daily Drinker-vs-Occasional Drinker
3.625000E-01
Daily Drinker-vs-Social Drinker
6.346600E-01
Weekly Drinker-vs-Occasional Drinker
4.055000E-01
Weekly Drinker-vs-Social Drinker
6.459600E-01
Occasional Drinker-vs-Social Drinker
7.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.880400E-01
Normal-vs-Grade 2
9.036200E-01
Normal-vs-Grade 3
9.084200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.289200E-01
Grade 1-vs-Grade 3
3.143400E-01
Grade 1-vs-Grade 4
9.880400E-01
Grade 2-vs-Grade 3
9.367400E-01
Grade 2-vs-Grade 4
9.036200E-01
Grade 3-vs-Grade 4
9.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.989700E-02
Normal-vs-NonDiabetic
1.040160E-02
Diabetic-vs-NonDiabetic
8.874600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.379880E-03
Normal-vs-NoPancreatitis
2.223800E-02
Pancreatitis-vs-NoPancreatitis
1.313810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.070250E-02
Normal-vs-N1
2.315700E-02
N0-vs-N1
3.011000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.380200E-03
Normal-vs-TP53-NonMutant
8.258200E-03
TP53-Mutant-vs-TP53-NonMutant
7.092600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
